Skip to main content
Displaying 611 - 620 of 4042
# Title Department Research Year
611 Design and Synthesis of Novel Isatin-Based derivatives Targeting Cell Cycle Checkpoint Pathways as Potential Anticancer Agents Department of Medicinal Chemistry 2020
612 Design and Synthesis of Novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases Department of Pharmaceutical Organic Chemistry 2020
613 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
614 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
615 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
616 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
617 Design of “Turn On” fluorometric nanoprobe based on nitrogen doped graphene quantum dots modified with β-cyclodextrin and vitamin B6 cofactor for selective sensing of dopamine in human serum Department of Pharmaceutical Analytical Chemistry 2020
618 Design of “Turn On” fluorometric nanoprobe based on nitrogen doped graphene quantum dots modified with β-cyclodextrin and vitamin B6 cofactor for selective sensing of dopamine in human serum Department of Pharmaceutical Analytical Chemistry 2020
619 Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives Department of Pharmaceutical Organic Chemistry 2020
620 Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety Department of Pharmaceutical Organic Chemistry 2020